Recent Acquisitions Fluxion Biosciences was acquired by Cell Microsystems Inc, presenting an opportunity for cross-selling and introducing Fluxion's innovative solutions to Cell Microsystems' customer base.

Cutting-Edge Product Launches The launch of IonFlux Mercury Ultra and BioFlux One showcases Fluxion's commitment to innovation, providing sales reps with new flagship products to promote and differentiate in the market.

Diverse Solution Portfolio With products like ERASE-Seq, IsoFlux, and BioFlux, Fluxion offers a diverse range of solutions catered to different research needs, creating multiple entry points for sales discussions.

Strong Research Backing Securing funding from the National Cancer Institute and publishing peer-reviewed research on ERASE-Seq demonstrate Fluxion's credibility and potential interest from research institutions looking for reliable technologies.

Strategic Market Expansion Fluxion's expansion into new markets with the launch of IsoFlux Cytation Imager and the release of targeted NGS liquid biopsy panels indicates growth opportunities for sales teams to tap into emerging segments.